clinical

Articles

While operating on a patient with chronic uveitis presents some challenges, there are a few pearls that may increase success.

Successful ocular surgery in patients with chronic uveitis

Measures of inflammation can predict treatment outcomes for patients

Measuring intraocular inflammation with standard care imaging

Standardization of Uveitis Nomenclature (SUN) Working Group utilized machine learning to create new uveitis classification criteria, inciting hope for implementation in clinical and research settings.

International coalition categorizes 25 subtypes of uveitis using machine learning

PDUFA action date of October 30, 2021, is assigned for investigational therapy with a proposed indication of treatment of macular edema associated with uveitis.



FDA accepts resubmitted Xipere NDA from Bausch Health, Clearside

Study results show the device offers an effective long-term option for patients.

Treating chronic uveitis with fluocinolone acetonide implants

Cheryl Guttman is a medical writer based in Deerfield, Ill.

Dexamethasone implant is key to treating non-infectious posterior segment uveitis 

Confirming uveitis treatment efficacy in study

Studies highlight the need for specialists and training programs focusing on the disease.

Why uveitis is a leading and underestimated cause of visual morbidity in patients

Bradley Smith, MD, presents at AAO 2020 on how fingolimod 0.5 mg, a first-line treatment for multiple sclerosis, may reduce both the number of relapses and disease progression in patients with relapsing-remitting MS as well as the incidence of uveitis.

AAO 2020: Fingolimod for MS offers disease control with no development of uveitis

Videos

Glenn J. Jaffe, MD, presents a summary of the results of a confirmatory study on a previous Phase III trial that examined sustained drug delivery for the treatment of uveitis, as well as data on the 36-month results in the second, confirmatory phase 3 study of YUTIQ.

AAO 2020: Study confirms Phase III results for uveitis treatment

Chronic cases can be difficult for retina specialists; treatment is satisfying.